Vishal Sikri - Feb 23, 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: President Advanced Diagnostics
Signature: /s/ Ali Olivo, Attorney-in-Fact
Stock symbol: NEO
Transactions as of: Feb 23, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/27/2024, 04:27 PM
Previous filing: Jun 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NEO	Common Stock						129K	Feb 23, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+42.3K		$0.00	42.3K	Feb 23, 2024	Common Stock	42.3K	$16.45	Direct	F8
transaction	NEO	Restricted Stock Unit	Award	$0	+25.3K		$0.00	25.3K	Feb 23, 2024	Common Stock	25.3K	$0.00	Direct	F6, F9
transaction	NEO	Performance Stock Unit	Award	$0	+25.3K		$0.00	25.3K	Feb 23, 2024	Common Stock	25.3K	$0.00	Direct	F6, F10
holding	NEO	Stock Option (Right to Buy)						319K	Feb 23, 2024	Common Stock	319K	$8.42	Direct	F2, F3
holding	NEO	Stock Option (Right to Buy)						39.7K	Feb 23, 2024	Common Stock	39.7K	$19.65	Direct	F4
holding	NEO	Restricted Stock Unit						21.2K	Feb 23, 2024	Common Stock	21.2K	$0.00	Direct	F5, F6
holding	NEO	Performance Stock Unit						21.2K	Feb 23, 2024	Common Stock	21.2K	$0.00	Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This balance includes 1,205 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
F2	On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
F3	On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4	On May 11, 2023, Mr. Sikri was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5	On May 11, 2023, Mr. Sikri was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F6	Once vested, the shares of common stock are not subject to expiration.
F7	On May 11, 2023, Mr. Sikri was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F8	On February 23, 2024, Mr. Sikri was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F9	On February 23, 2024, Mr. Sikri was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10	On February 23, 2024, Mr. Sikri was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.